Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastoma.
about
Chemotherapy for children with medulloblastomaHepatic late adverse effects after antineoplastic treatment for childhood cancerAdvances in managing medulloblastoma and intracranial primitive neuro-ectodermal tumorsMagnetic resonance imaging patterns of treatment-related toxicity in the pediatric brain: an update and review of the literature.Children's Oncology Group's 2013 blueprint for research: central nervous system tumors.Overcoming multiple drug resistance mechanisms in medulloblastoma.Case report: long-term survival of an infant syndromic patient affected by atypical teratoid-rhabdoid tumor.High levels of PROM1 (CD133) transcript are a potential predictor of poor prognosis in medulloblastomaMedulloblastoma subgroups remain stable across primary and metastatic compartments.Docosahexaenoic acid (DHA) sensitizes brain tumor cells to etoposide-induced apoptosisAdvances in paediatric cancer treatmentRisk stratification of childhood medulloblastoma in the molecular era: the current consensus.The potential impact of tumour biology on improved clinical practice for medulloblastoma: progress towards biologically driven clinical trials.Pediatric neuro-oncology: current status and future directions.Neurocognitive function after radiotherapy for paediatric brain tumours.Impact of induction chemotherapy, hyperfractionated accelerated radiotherapy and high-dose thiotepa on brain volume loss and functional status of children with primitive neuroectodermal tumour.Long-term safety of growth hormone replacement therapy after childhood medulloblastoma and PNET: it is time to set aside old concerns.Quality of life in long-term survivors treated for metastatic medulloblastoma with a hyperfractionated accelerated radiotherapy (HART) strategy.Role of eculizumab in a pediatric refractory gemcitabine-induced thrombotic microangiopathy: a case report.The UK Experience of a Treatment Strategy for Pediatric Metastatic Medulloblastoma Comprising Intensive Induction Chemotherapy, Hyperfractionated Accelerated Radiotherapy and Response Directed High Dose Myeloablative Chemotherapy or Maintenance ChemA rare case of adult medulloblastoma with spinal metastasis.Management and outcome of children and adolescents with non-medulloblastoma CNS embryonal tumors in Spain: room for improvement in standards of care.Relapse in medulloblastoma: what can be done after abandoning high-dose chemotherapy? A mono-institutional experience.MRI abnormalities in children following sequential chemotherapy, hyperfractionated accelerated radiotherapy and high-dose thiotepa for high-risk primitive neuroectodermal tumours of the central nervous system.Pediatric infratentorial ependymoma: prognostic significance of anaplastic histology.Our panel of experts highlight the most important research articles across the spectrum of topics relevant to the field of CNS oncology.Metastatic spread outside the central nervous system of anaplastic medulloblastoma associated with a spinal-peritoneal shunt immediately after radiotherapy.Reply to Comment on: The UK Experience of a Treatment Strategy for Pediatric Metastatic Medulloblastoma Comprising Intensive Induction Chemotherapy, Hyperfractionated Accelerated Radiotherapy, and Response-Directed High-Dose Myeloablative ChemotheraComment on: The UK Experience of a Treatment Strategy for Pediatric Metastatic Medulloblastoma Comprising Intensive Induction Chemotherapy, Hyperfractionated Accelerated Radiotherapy, and Response Directed High-Dose Myeloablative Chemotherapy or MaiDeveloping quality assurance for pediatric autologous stem cell transplants in England: results of a 3-year national audit of activity and engraftment by treatment centre.Initial response with paradoxical deterioration following bevacizumab for cerebral radiation necrosis.Tandem high-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk medulloblastoma or supratentorial primitive neuro-ectodermic tumors.[The chemotherapy before or after radiation therapy does not influence survival of children with high-risk medulloblastomas: results of the multicenter and randomized study of the Pediatric Oncology Group (POG 9031)].Histological variants of medulloblastoma are the most powerful clinical prognostic indicators.Long-term results of combined preradiation chemotherapy and age-tailored radiotherapy doses for childhood medulloblastoma.
P2860
Q24186770-E5827498-5E3B-4CA9-9EFA-FA36F73DDE8CQ24235525-F7A8BA64-7FEE-4A80-8464-037C585E6A55Q26866408-8E970977-7935-4335-8CC5-ACB65E45E603Q31147678-4B4ABC3D-1C16-4524-9617-09C9EA264B19Q34285237-9F81DED2-BB27-44B7-813E-B695F637E078Q34500602-E22A2FFF-9979-46C9-908A-71C59D17B48CQ34627709-3559A6C1-10B1-4D36-86E3-B186F670C071Q34977386-FE8119BF-7138-4854-9478-30E02FBF1600Q35099027-04AE05C7-0D09-4DD1-8544-1E7692187465Q35510360-A84E016F-6B64-4F0B-B3A4-203FB05E3689Q36508630-3D3F400C-4247-4FD7-90F9-91A415018E48Q36901551-BD2A774C-EB8C-4198-B727-70AB22337B82Q37564205-3DA162AA-8FA4-4AC7-9D7A-2D13BD219851Q38035070-DC4C0B82-9C7C-4DCD-B22C-958BCB72C638Q38042263-C88415DC-AFB1-4875-815B-C24AF4134048Q38783476-E7098B55-F0D8-45F5-A70C-A19CED61C9F7Q39259845-C5BCD221-6E9E-4190-BCB7-38DE9FED144FQ40096929-983F83BF-0DB4-4AAB-956D-2845822991D3Q41146886-C68FEF8D-C58B-457A-9601-6DE8F7492950Q41482342-42BB7B25-4647-4E6B-90A8-47B41B4C8464Q41854674-8C963FF2-72C0-430E-8CD4-EE673FC62C8EQ47296254-48E6A780-82F4-4E46-AFC5-35856DC8F58FQ48258994-F22C8C9D-E2F2-479A-AE50-A19D5C10BBEEQ48540743-C6B96CC2-F3D9-40BA-9EAB-A411F1410841Q48935560-23168180-DBF6-468F-88E1-1A18FC522EF5Q50090370-1215D06B-4003-4CB9-9EA1-770B3DF86CAEQ50791359-02A9F156-CF4E-41E3-A539-F202D3F6FCC3Q50878867-617B454E-1C4C-443A-A6A5-C6332379FD9FQ50892048-EB611B9F-E32F-4793-B77D-BCE943E03022Q52782465-9E39F43C-5A60-4059-B911-A7009AF188F9Q54273273-8256EB3F-57F1-439F-BC13-EDA16694E7B2Q55461058-E76C1966-6C9E-4732-89A1-C34B69F33929Q55461345-29A598E3-26BA-4615-9EEB-2104233267A1Q55462103-0AD640A0-C744-4153-AEB8-B86798E81E69Q55462259-836F0A5F-E598-4111-A4FF-B119102106BC
P2860
Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastoma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Hyperfractionated accelerated ...... or metastatic medulloblastoma.
@en
Hyperfractionated accelerated ...... or metastatic medulloblastoma.
@nl
type
label
Hyperfractionated accelerated ...... or metastatic medulloblastoma.
@en
Hyperfractionated accelerated ...... or metastatic medulloblastoma.
@nl
prefLabel
Hyperfractionated accelerated ...... or metastatic medulloblastoma.
@en
Hyperfractionated accelerated ...... or metastatic medulloblastoma.
@nl
P2093
P50
P356
P1476
Hyperfractionated accelerated ...... or metastatic medulloblastoma.
@en
P2093
Bianca Pollo
Carlo Solero
Claudio Favre
Daria Riva
Emilia Pecori
Felice Giangaspero
Franca Fossati-Bellani
Graziella Cefalo
Serena Berretta
P304
P356
10.1200/JCO.2008.18.4176
P407
P50
P577
2008-12-15T00:00:00Z